Infectious Disease

Novel therapeutic approach may help cure patients with HIV in the future.

The second of 4-part interview with an infectious disease expert examines weighing the short-term high cost of treating HCV with curative drugs versus the long-term costs of treating the disease.

Mark Wainberg, PhD was an influential researcher from the start of the AIDS epidemic.

Part 1 of a 4-part interview with an infectious disease expert explores treatment advances in HIV since the AIDS epidemic in the 1980s.

Novel drug delivery system steadily releases preventive HIV drugs over an extended period of time.

Top news of the day from across the healthcare landscape.

Technique will help scientists develop an effective HIV vaccine.

Poorer health outcomes found in perinatally HIV-infected youth.

New tuberculosis cases have declined over the past 5 years, but new data show rates are up for TB/HIV coinfections.

Adults who receive vaccination reimbursement through an employer-sponsored pharmacy insurance benefit may be more likely to receive vaccinations, according to data revealed in a poster presentation at the American Pharmacists Association (APhA) 2017 Annual Meeting & Exposition in San Francisco.

Marker helps differentiate dormant HIV-infected cells from their health counterpart cells.

Antibody therapy enables efficacious control of HIV-like virus in monkeys.

Round 2 of study finds a reduction in start time of antiretroviral therapy for HIV treatment.

Treatment with Accolate or Singulair could prevent influenza pneumonia infections.

Insulin could become a new therapeutic option for HIV-associated neurocognitive disorders.

Hypertension can cause cardiovascular risk factors in patients with HIV.

Brain scans could help diagnose patients with HIV-related cognitive issues.

Non-inferiority found between tenofovir disoproxil fumarate and tenofovir alafenamide regimens.

Regimens with Descovy show non-inferiority to those containing Truvada.

Top news of the day from across the health care landscape.

Scientists continue to pursue the development of an HIV cure.

A New Zealand woman who was intentionally infected with HIV and was the center of a high profile criminal case faces down numerous challenges related to the virus.

Scientists utilized nanotechnology to improve HIV treatments.

Top news of the day from across the health care landscape.

Fibroblasts in the gastrointestinal tract help HIV infect immune cells.